NIHR and Sanofi announce first patient enrolled in large European clinical study to investigate protection against RSV, the leading cause of infant hospitalisation worldwide Reading, 12 August 2022. Sanofi (EURONEXT: SAN and NASDAQ: SNY) and the National Institute for Health and Care Research (NIHR) have today.
NIHR and Sanofi Announce First Patient Enrolled in Large European Clinical Study to Investigate Protection Against RSV, the Leading Cause of Infant Hospitalisation Worldwide streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Best Emollients for Eczema trial has found that no one type of moisturizer is better than another. This study, the first in the world to directly compare different types of moisturizers, highlights the importance of patient education and choice when deciding which moisturizers to use for children with eczema.
A major trial, which is the first in the world to directly compare different types of moisturisers to treat eczema, has found that no one type of moisturiser is better than another.The results of the Best Emollients for Eczema trial highlight the imp
The Best Emollients for Eczema trial has found that no one type of moisturiser is better than another. This study, the first in the world to directly..